1Brandi G, Pantaleo MA, Galli C, et al. Hypersensitivity reactions related to oxaliplatin (OHP) [J]. Br J Cancer, 2003, 89(3) :477-481.
2Thomas RR, Quinn MG, Schuler B, et al. Hypersensitivity and idiosyncratic reactions to oxaliplatin [J]. Cancer, 2003, 97(9) : 2301-2307.
3Siu SW, Chan RT, Au GK. Hypersensitivity reactions to oxaliplatin: experience in a single institute [J]. Ann Oncol, 2006,17(2) :259-261.
4Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes [J]. Lancet, 1977,1 ( 8009 ) : 466-469.
5Polyzos A, Tsavaris N, Gogas H, et al. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience [J]. Oncology, 2009,76( 1 ) : 36-41.
6Maindrault-Goebel F, Andre T, Tournigand C, et al. Allergictype reactions to oxaliplatin: retrospective analysis of 42 patients [J ]. Eur J Cancer, 2005,41 (15) : 2262-2267.
7Lee MY, Yang MH, Liu JH, et al. Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication [J]. Support Care Cancer, 2007, 15(1):89-93.
8Larzilliere I, Brandissou S, Breton P. et al. Anaphylaetic reaction to oxaliplatin: a case report [J].Am J Gastroenterol, 1999,94( 11 ) :3387-3388.
9Finkehnan FD, Rothenberg ME, Brandt EB, et al. Molecular mechanisms of anaphylaxis: lessons from studies with murine models [J].J Allergy Clin hnmunol, 2005,115(3):449-457.
10Strait R, Morrist SC, Finkelman FD. Cytokine enhancement of anaphylaxis [J]. No~artis Found Syrup, 2004. 257 : 80-91.
